Ledger.Open graph →

SEC Form D · Amendment · filed March 31, 2016

Semma Therapeutics, Inc

Offering

$25.0M

Sold

$15.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Jim Scopa · Cambridge, MADirector Robert Millman · Cambridge, MAExec · Director William Sahlman · Cambridge, MADirector Todd Foley · Cambridge, MAExec · Director Stephen Knight · Cambridge, MADirector Kingsley Taft · Boston, MAExec Mitch Finer · Cambridge, MADirector Dominick J. D'Eramo · WILMINGTON, DEDirector Russell A. Radoff · Houston, TXDirector Garrett Finney · Houston, TXExec J. A. Gonzalez · Houston, TXExec · Director Michael Bland · Houston, TXDirector Mark Galvin · Portsmouth, NHExec · Director William Moon · Ruston, LAExec · Director David M. Talla · Los Angeles, CADirector Michael Episcope · chicago, ILExec · Director David Scherer · Chicago, ILDirector Richard L. Latto · Stamford, CTExec · Director Shaun J. Mcnulty · Babraham, Cambridge, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗